Dr. Mukesh Kumar, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Years since graduation
- 24
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 570
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
GA license 066710 -
Internal Medicine Physician
MN license 50678
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Piedmont Newnan Hospital, Inc Newnan, GA
- Piedmont Columbus Regional Midtown Columbus, GA
- St Francis Hospital- Emory Healthcare Columbus, GA
- Piedmont Columbus Regional Northside Columbus, GA
Medical groups
- The Medical Center, Inc. (25 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 570
- Services billed
- 1,750
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 1,341 | 491 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 308 | 98 |
| Established patient office or other outpatient visit, 40-54 minutes | 198 | 87 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 97 | 82 |
| New patient office or other outpatient visit, 45-59 minutes | 58 | 58 |
| New patient office or other outpatient visit, 60-74 minutes | 39 | 39 |
| Established patient office or other outpatient visit, 20-29 minutes | 39 | 36 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 29 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Columbus, GA | 308 |
| Ondansetron Hcl Other prescribers in Columbus, GA | 154 |
| Prednisone Other prescribers in Columbus, GA | 138 |
| Letrozole Other prescribers in Columbus, GA | 136 |
| Dexamethasone Other prescribers in Columbus, GA | 125 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Columbus, GA | 125 |
| Promethazine Hcl Other prescribers in Columbus, GA | 119 |
| Lidocaine-Prilocaine (lidocaine/prilocaine) Other prescribers in Columbus, GA | 114 |
| Eliquis (apixaban) Other prescribers in Columbus, GA | 112 |
| Potassium Chloride Other prescribers in Columbus, GA | 109 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 23 payments worth $12,111 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $6,440 |
|---|---|
| Avyxa Pharma, LLC | $3,833 |
| Janssen Scientific Affairs, LLC | $1,388 |
| Merck Sharp & Dohme LLC | $293 |
| Gilead Sciences, Inc. | $77.99 |
| Array Biopharma Inc | $28.13 |
| AbbVie Inc. | $18.45 |
| Genzyme Corporation | $16.56 |
| Consulting Fee | $7,023 |
|---|---|
| Travel and Lodging | $2,460 |
| Compensation for services other than consulting (speaking, faculty) | $2,000 |
| Food and Beverage | $550 |
| Education | $77.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Jul 28, 2025 | Consulting Fee IMFINZI · Oncology | $3,015 |
| AstraZeneca Pharmaceuticals LP May 22, 2025 | Consulting Fee | $2,345 |
| Avyxa Pharma, LLC Nov 8, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,000 |
| Janssen Scientific Affairs, LLC Mar 31, 2025 | Consulting Fee TECVAYLI · Oncology | $1,388 |
| Avyxa Pharma, LLC Nov 8, 2025 | Travel and Lodging travel to MIAMI BEACH, FL · in-kind | $682 |
| Avyxa Pharma, LLC Nov 8, 2025 | Travel and Lodging travel to MIAMI BEACH, FL · in-kind | $417 |
| AstraZeneca Pharmaceuticals LP Jul 18, 2025 | Travel and Lodging IMFINZI · Oncology · travel to Miami, FL · in-kind Company’s descriptionConsulting Expenses | $374 |
| Avyxa Pharma, LLC Nov 8, 2025 | Travel and Lodging travel to MIAMI BEACH, FL · in-kind | $359 |
| AstraZeneca Pharmaceuticals LP Jul 19, 2025 | Travel and Lodging IMFINZI · Oncology · travel to Miami, FL · in-kind Company’s descriptionConsulting Expenses | $281 |
| Merck Sharp & Dohme LLC Jul 27, 2025 | Consulting Fee KEYTRUDA · ONCOLOGY Company’s descriptionPayment made to Third Party Organization not to Physician. | $275 |
All 13 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Avyxa Pharma, LLC Nov 8, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,000 |
| Avyxa Pharma, LLC Nov 8, 2025 | Travel and Lodging travel to MIAMI BEACH, FL · in-kind | $682 |
| Avyxa Pharma, LLC Nov 8, 2025 | Travel and Lodging travel to MIAMI BEACH, FL · in-kind | $417 |
| Avyxa Pharma, LLC Nov 8, 2025 | Travel and Lodging travel to MIAMI BEACH, FL · in-kind | $359 |
| Gilead Sciences, Inc. Oct 13, 2025 | Education Trodelvy · ONC · in-kind Company’s description;4203865;GTF;10671867 | $77.99 |
| AstraZeneca Pharmaceuticals LP Sep 1, 2025 | Travel and Lodging IMFINZI · Oncology · travel to Miami, FL Company’s descriptionConsulting Expenses | $275 |
| AstraZeneca Pharmaceuticals LP Jul 28, 2025 | Consulting Fee IMFINZI · Oncology | $3,015 |
| Merck Sharp & Dohme LLC Jul 27, 2025 | Consulting Fee KEYTRUDA · ONCOLOGY Company’s descriptionPayment made to Third Party Organization not to Physician. | $275 |
| AstraZeneca Pharmaceuticals LP Jul 19, 2025 | Travel and Lodging IMFINZI · Oncology · travel to Miami, FL · in-kind Company’s descriptionConsulting Expenses | $281 |
| AstraZeneca Pharmaceuticals LP Jul 19, 2025 | Travel and Lodging IMFINZI · Oncology · travel to Miami, FL · in-kind Company’s descriptionConsulting Expenses | $72.00 |
| AstraZeneca Pharmaceuticals LP Jul 18, 2025 | Travel and Lodging IMFINZI · Oncology · travel to Miami, FL · in-kind Company’s descriptionConsulting Expenses | $374 |
| AstraZeneca Pharmaceuticals LP May 22, 2025 | Consulting Fee | $2,345 |
| Janssen Scientific Affairs, LLC Mar 31, 2025 | Consulting Fee TECVAYLI · Oncology | $1,388 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.